Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literatureJeries Abu‐Hanna, Mohammad Eddama, Marilena Loizidou et al.|Clinical Epigenetics|2022Cited by 69
Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary HypertensionLucie H. Clapp, Jigisha Patel, Jeries Abu‐Hanna|Unknown|2020Cited by 13
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertensionJeries Abu‐Hanna, Lucie H. Clapp, Evangelos Anastasakis et al.|Vascular Pharmacology|2023Cited by 8
Impact of treprostinil on dynamin-related protein 1 (DRP1) and mitochondrial fragmentation in pulmonary arterial hypertension (PAH).Jeries Abu‐Hanna, Lucie H. Clapp, Jan‐Willem Taanman et al.|Unknown|2018Cited by 5
The Role of the K2P Channels TASK‐1, TREK‐1 and TREK‐2 in the Use of Treprostinil Therapy in Pulmonary Arterial HypertensionKevin P. Cunningham, Alistair Mathie, Lucie H. Clapp et al.|The FASEB Journal|2018Cited by 4